Loading…
Lobbying Spend
—
Filings
28
Firms Hired
1
Active Period
2013–2020
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Lower Costs, More Cures Act of 2019
2020 · second_quarter · Firm: THE D MAJOR GROUP
Worked on industry concerns related to S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; S.1895, the Lower Health Care Costs Act; and S. 3129 and HR 19, the Lower Costs, More Cures Act of 2019.
Client expense: — · Firm income: $60,000
Matched citations: HR 19
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
2020 · second_quarter · Firm: THE D MAJOR GROUP
Monitored vaccine and other R&D funding levels as related to HR 6074, the Coronavirus Preparedness & Response Supplemental Appropriations Act; HR 6201, the Families First Coronavirus Response Act; and S. 3548, the Coronavirus Aid, Relief, and Economic Security Act.
Client expense: — · Firm income: $60,000
Matched citations: HR 6074
Families First Coronavirus Response Act
2020 · second_quarter · Firm: THE D MAJOR GROUP
Monitored vaccine and other R&D funding levels as related to HR 6074, the Coronavirus Preparedness & Response Supplemental Appropriations Act; HR 6201, the Families First Coronavirus Response Act; and S. 3548, the Coronavirus Aid, Relief, and Economic Security Act.
Client expense: — · Firm income: $60,000
Matched citations: HR 6201
Hatch-Waxman Integrity Act of 2019
2020 · second_quarter · Firm: THE D MAJOR GROUP
Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 990
Affordable Prescriptions for Patients Act of 2019
2020 · second_quarter · Firm: THE D MAJOR GROUP
Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 1416
Worked on industry concerns related to S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; S.1895, the Lower Health Care Costs Act; and S. 3129 and HR 19, the Lower Costs, More Cures Act of 2019.
Client expense: — · Firm income: $60,000
Matched citations: S.1895
Prescription Drug Pricing Reduction Act of 2019
2020 · second_quarter · Firm: THE D MAJOR GROUP
Worked on industry concerns related to S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; S.1895, the Lower Health Care Costs Act; and S. 3129 and HR 19, the Lower Costs, More Cures Act of 2019.
Client expense: — · Firm income: $60,000
Matched citations: S. 2543
Lower Costs, More Cures Act of 2019
2020 · second_quarter · Firm: THE D MAJOR GROUP
Worked on industry concerns related to S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; S.1895, the Lower Health Care Costs Act; and S. 3129 and HR 19, the Lower Costs, More Cures Act of 2019.
Client expense: — · Firm income: $60,000
Matched citations: S. 3129
Hatch-Waxman Integrity Act of 2019
2020 · second_quarter · Firm: THE D MAJOR GROUP
Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 344
Monitored vaccine and other R&D funding levels as related to HR 6074, the Coronavirus Preparedness & Response Supplemental Appropriations Act; HR 6201, the Families First Coronavirus Response Act; and S. 3548, the Coronavirus Aid, Relief, and Economic Security Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 3548
Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 440
Lower Costs, More Cures Act of 2019
2020 · first_quarter · Firm: THE D MAJOR GROUP
Worked on industry concerns related to S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; S.1895, the Lower Health Care Costs Act; and S. 3129 and HR 19, the Lower Costs, More Cures Act of 2019.
Client expense: — · Firm income: $60,000
Matched citations: HR 19
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
2020 · first_quarter · Firm: THE D MAJOR GROUP
Monitored vaccine and other R&D funding levels as related to HR 6074, the Coronavirus Preparedness & Response Supplemental Appropriations Act; HR 6201, the Families First Coronavirus Response Act; and S. 3548, the Coronavirus Aid, Relief, and Economic Security Act.
Client expense: — · Firm income: $60,000
Matched citations: HR 6074
Families First Coronavirus Response Act
2020 · first_quarter · Firm: THE D MAJOR GROUP
Monitored vaccine and other R&D funding levels as related to HR 6074, the Coronavirus Preparedness & Response Supplemental Appropriations Act; HR 6201, the Families First Coronavirus Response Act; and S. 3548, the Coronavirus Aid, Relief, and Economic Security Act.
Client expense: — · Firm income: $60,000
Matched citations: HR 6201
Hatch-Waxman Integrity Act of 2019
2020 · first_quarter · Firm: THE D MAJOR GROUP
Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 990
Affordable Prescriptions for Patients Act of 2019
2020 · first_quarter · Firm: THE D MAJOR GROUP
Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 1416
Worked on industry concerns related to S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; S.1895, the Lower Health Care Costs Act; and S. 3129 and HR 19, the Lower Costs, More Cures Act of 2019.
Client expense: — · Firm income: $60,000
Matched citations: S.1895
Prescription Drug Pricing Reduction Act of 2019
2020 · first_quarter · Firm: THE D MAJOR GROUP
Worked on industry concerns related to S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; S.1895, the Lower Health Care Costs Act; and S. 3129 and HR 19, the Lower Costs, More Cures Act of 2019.
Client expense: — · Firm income: $60,000
Matched citations: S. 2543
Lower Costs, More Cures Act of 2019
2020 · first_quarter · Firm: THE D MAJOR GROUP
Worked on industry concerns related to S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; S.1895, the Lower Health Care Costs Act; and S. 3129 and HR 19, the Lower Costs, More Cures Act of 2019.
Client expense: — · Firm income: $60,000
Matched citations: S. 3129
Hatch-Waxman Integrity Act of 2019
2020 · first_quarter · Firm: THE D MAJOR GROUP
Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 344
Monitored vaccine and other R&D funding levels as related to HR 6074, the Coronavirus Preparedness & Response Supplemental Appropriations Act; HR 6201, the Families First Coronavirus Response Act; and S. 3548, the Coronavirus Aid, Relief, and Economic Security Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 3548
Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 440
Lower Costs, More Cures Act of 2019
2019 · fourth_quarter · Firm: THE D MAJOR GROUP
Worked on industry concerns related to S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; S.1895, the Lower Health Care Costs Act; and S. 3129 and HR 19, the Lower Costs, More Cures Act of 2019.
Client expense: — · Firm income: $50,000
Matched citations: HR 19
Hatch-Waxman Integrity Act of 2019
2019 · fourth_quarter · Firm: THE D MAJOR GROUP
Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 990
Affordable Prescriptions for Patients Act of 2019
2019 · fourth_quarter · Firm: THE D MAJOR GROUP
Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.
Client expense: — · Firm income: $50,000
Matched citations: S. 1416
Source: Senate LDA